Liminal BioSciences Inc. PFSCF

Primary Symbol: LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.

NDAQ:LMNL - Post by User

Liminal BioSciences Inc. > lets go back to 2021, price target 22$:)

<< Previous

Bullboard Posts

Next >>

Comment by stockbuphoonon Mar 27, 2021 4:21pm

49 Views

Post# 32893492

RE:lets go back to 2021, price target 22$:)

Regardless if the lawsuit is won, the incredibly weak management (a finance guy) will have to focus on it spending cash on lawyers along with selling off Plasma pieces. They are running out of money quickly without any results. What accomplishments has this company had in last 4 years spending over half a BILLION $$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$

$22? That's really cute... laughable.

realstocky wrote:

LMNL Analyst Ratings

Consensus Buy

Based on 3 analysts offering recommendations for lmnl in the last 3 months.

Analyst Firms Making Recommendations

BLOOM BURTON&CO

ECHELON WEALTH

PIPER SANDLER

Analyst

$22

https://www.nasdaq.com/market-activity/stocks/lmnl/analyst-research